Bio-IT World September 15, 2022
Deborah Borfitz

The greater New York metropolitan area is the epicenter of an ambitious human genome sequencing research project newly launched by Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai in collaboration with the Regeneron Genetics Center (part of biotechnology company Regeneron). If the vision is realized, Mount Sinai will enroll a million patients into a study over the next five years that will sequence and analyze the DNA in their blood to tease out the role of genetics and environment on health, according to Alexander W. Charney, M.D., Ph.D., associate professor of psychiatry, and genetics and genomic sciences, as well as leader of the Mount Sinai Million Health Discoveries Program.

“Genetics is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Pharma / Biotech, Precision Medicine, Provider
Nation's 1st double lung-liver transplant performed at Northwestern
Physician Compensation Continues To Decline, Despite A Dire Shortage
340B profit exceeds charity care spending for 85% of disproportionate share hospitals: Report
Ascension continues selling spree
Healthcare security culture steadily improving, but gaps remain

Share This Article